NEIL3 and hepatocellular carcinoma: In HCC, NEIL3 activates a key transcription factor, twist family bHLH transcription factor 1 (TWIST1), leading to an increase in the expression of the drug efflux gene and drug resistance in EMT (Lai et al., 2022).